BioRestorative Therapies, Inc. (BRTX) Net Income by Year
BioRestorative Therapies, Inc. reported a net loss of $14.2M in fiscal year 2025. This represents a decrease of 58.6% from the prior fiscal year. Over the trailing 12 months, Q2 FY2025 through Q1 FY2026, the same line adds up to a $11.1M net loss. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters BioRestorative Therapies, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BRTX Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.
BRTX Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More BioRestorative Therapies, Inc. financials
Frequently Asked Questions
What was BioRestorative Therapies, Inc.'s net income in fiscal year 2025?
BioRestorative Therapies, Inc. reported a net loss of $14.2M in fiscal year 2025.
How fast is BioRestorative Therapies, Inc.'s net income growing?
BioRestorative Therapies, Inc. (BRTX) net income fell by 58.6% year over year, from -$9.0M to -$14.2M in fiscal year 2025.
What is BioRestorative Therapies, Inc.'s net income over the last twelve months?
BioRestorative Therapies, Inc. (BRTX) reported a $11.1M net loss over the trailing 12 months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.
What was BioRestorative Therapies, Inc.'s net income in the most recent quarter?
BioRestorative Therapies, Inc. (BRTX) reported -$2.2M in net income in Q1 2026. This represents an increase of 59.7% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what BioRestorative Therapies, Inc. (BRTX) reported on that line in every period on record.